|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of the combination of MK-4827 and temozolomide that can be given to patients
with advanced solid cancers. The effects of the study drugs at different dose
levels and the safety of the study drugs will also be studied.
You are also being asked to take part in optional procedures, which are
described in a separate consent form.